Trials / Recruiting
RecruitingNCT05530265
Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA)
Effect of Smart Watch and App on Positive Airway Pressure Adherence in Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 22 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Continuous positive airway pressure (CPAP) is highly effective in treating obstructive sleep apnea (OSA). However, this treatment modality relies heavily on patient adherence, and poor adherence to the treatment limits its effectiveness in treating OSA. Strategies to augment adherence are needed in the management of OSA. The smart watch and linked app provide various health information, including sleep, snoring or oxygen saturation during sleep, exercise, blood pressure, and electrocardiogram. The smart watch and linked app could potentially improve adherence to positive airway pressure (PAP) treatment. This randomized controlled trial (RCT) aimed to examine whether the use of smart watch and app can increase PAP adherence in patients with OSA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | the smart watch and Samsung Health app | Use the smart watch (Galaxy Watch 4, Samsung Electronics Co., Ltd., Korea) and the Samsung Health app (Samsung Electronics Co., Ltd., Korea) for 90 days of positive airway pressure treatment |
Timeline
- Start date
- 2022-08-22
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2022-09-07
- Last updated
- 2024-04-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05530265. Inclusion in this directory is not an endorsement.